cilostazol has been researched along with Depression in 4 studies
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dizziness was significantly improved in the cilostazol group versus the aspirin group (P<0." | 9.16 | Cilostazol versus aspirin therapy in patients with chronic dizziness after ischemic stroke. ( Johkura, K; Kudo, Y; Kuroiwa, Y; Momoo, T; Nakae, Y; Yoshida, TN, 2012) |
| "The aim of this study was to determine the effects and underlying mechanism of aripiprazole (APZ) augmentation for cilostazol (CLS)-treated post-ischemic stroke mice that were exposed to chronic mild stress (CMS)." | 7.85 | Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke. ( Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK, 2017) |
| "Our results suggest that phosphodiesterase 3 inhibitor cilostazol may have anti-depressant effects on post-stroke depression through inhibition of neurodegeneration in the primary lesion and secondary extrafocal sites and promotion of neurogenesis." | 7.83 | Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. ( Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK, 2016) |
| "Dizziness was significantly improved in the cilostazol group versus the aspirin group (P<0." | 5.16 | Cilostazol versus aspirin therapy in patients with chronic dizziness after ischemic stroke. ( Johkura, K; Kudo, Y; Kuroiwa, Y; Momoo, T; Nakae, Y; Yoshida, TN, 2012) |
| "The aim of this study was to determine the effects and underlying mechanism of aripiprazole (APZ) augmentation for cilostazol (CLS)-treated post-ischemic stroke mice that were exposed to chronic mild stress (CMS)." | 3.85 | Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke. ( Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK, 2017) |
| "Our results suggest that phosphodiesterase 3 inhibitor cilostazol may have anti-depressant effects on post-stroke depression through inhibition of neurodegeneration in the primary lesion and secondary extrafocal sites and promotion of neurogenesis." | 3.83 | Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. ( Choi, BT; Hong, KW; Kim, HN; Kim, YR; Shin, HK, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuelezz, SA | 1 |
| Hendawy, N | 1 |
| Kim, YR | 2 |
| Kim, HN | 2 |
| Hong, KW | 2 |
| Shin, HK | 2 |
| Choi, BT | 2 |
| Johkura, K | 1 |
| Yoshida, TN | 1 |
| Kudo, Y | 1 |
| Nakae, Y | 1 |
| Momoo, T | 1 |
| Kuroiwa, Y | 1 |
1 trial available for cilostazol and Depression
| Article | Year |
|---|---|
Cilostazol versus aspirin therapy in patients with chronic dizziness after ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Brain Stem; Cerebellum; Cerebrovascular Circulatio | 2012 |
3 other studies available for cilostazol and Depression
| Article | Year |
|---|---|
Insights into the potential antidepressant mechanisms of cilostazol in chronically restraint rats: impact on the Nrf2 pathway.
Topics: Animals; Antidepressive Agents; Antioxidants; Cilostazol; Corticosterone; Depression; Depressive Dis | 2018 |
Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cilostazol; Corpus Striatum; Cyclic AMP Response Element | 2016 |
Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke.
Topics: Animals; Antidepressive Agents; Aripiprazole; Atrophy; Behavior, Animal; Brain; Cell Differentiation | 2017 |